Michael Weiser, Director at Hana Biosciences Inc (HNAB), bought 1,000 shares at $7.83 ($8K) on 2006-07-11, disclosed to the SEC on 2006-07-11.
Open-market purchase of $8k HNAB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.83 | 200 | $2K | 19.9% |
| 2 | $7.85 | 300 | $2K | 29.9% |
| 3 | $7.91 | 200 | $2K | 20.1% |
| 4 | $7.95 | 300 | $2K | 30.2% |
| Total | $7.89 avg | 1,000 | $8K | 100% |
| Filing → |
| ZIOP | SELL | 2011-05-26 | $98K | — | Filing → |
| CHTP | BUY | 2008-10-06 | $3K | — | Filing → |
| CHTP | BUY | 2008-09-24 | $4K | — | Filing → |